TBCA

gene
On this page

Summary

TBCA (tubulin folding cofactor A, HGNC:11579) is a protein-coding gene on chromosome 5q14.1, encoding Tubulin-specific chaperone A (O75347). Tubulin-folding protein; involved in the early step of the tubulin folding pathway. It is a common-essential gene (DepMap: required in 92.5% of cancer cell lines).

The product of this gene is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. This gene encodes chaperonin cofactor A. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 6902 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 14 total
  • Druggable target: yes
  • Cancer dependency (DepMap): dependent in 92.5% of screened cell lines (common-essential)
  • MANE Select transcript: NM_004607

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:11579
Approved symbolTBCA
Nametubulin folding cofactor A
Location5q14.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000171530
Ensembl biotypeprotein_coding
OMIM610058
Entrez6902

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 11 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000306388, ENST00000380377, ENST00000517679, ENST00000517881, ENST00000518218, ENST00000518338, ENST00000520039, ENST00000520361, ENST00000522370, ENST00000651106, ENST00000932727, ENST00000932728, ENST00000932729

RefSeq mRNA: 3 — MANE Select: NM_004607 NM_001297738, NM_001297740, NM_004607

CCDS: CCDS4040, CCDS75263, CCDS78024

Canonical transcript exons

ENST00000380377 — 4 exons

ExonStartEnd
ENSE000014846957777620577776339
ENSE000021203547769116677691498
ENSE000035106317769326677693352
ENSE000036849767770824277708347

Expression profiles

Bgee: expression breadth ubiquitous, 180 present calls, max score 99.27.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 194.6560 / max 2017.0104, expressed in 1828 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
62193116.54731827
6219278.08381812
621940.02492

Top tissues by expression

257 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right adrenal gland cortexUBERON:003582799.27gold quality
left adrenal glandUBERON:000123499.24gold quality
left adrenal gland cortexUBERON:003582599.23gold quality
right adrenal glandUBERON:000123399.22gold quality
ganglionic eminenceUBERON:000402399.22gold quality
cortical plateUBERON:000534399.21gold quality
adrenal tissueUBERON:001830399.21gold quality
ventricular zoneUBERON:000305399.06gold quality
islet of LangerhansUBERON:000000698.94gold quality
left ovaryUBERON:000211998.94gold quality
adenohypophysisUBERON:000219698.93gold quality
mucosa of stomachUBERON:000119998.89gold quality
popliteal arteryUBERON:000225098.80gold quality
tibial arteryUBERON:000761098.80gold quality
right ovaryUBERON:000211898.78gold quality
right uterine tubeUBERON:000130298.76gold quality
olfactory segment of nasal mucosaUBERON:000538698.72gold quality
metanephros cortexUBERON:001053398.72gold quality
body of stomachUBERON:000116198.71gold quality
muscle layer of sigmoid colonUBERON:003580598.71gold quality
endocervixUBERON:000045898.70gold quality
right lungUBERON:000216798.70gold quality
left coronary arteryUBERON:000162698.66gold quality
body of uterusUBERON:000985398.66gold quality
left uterine tubeUBERON:000130398.63gold quality
C1 segment of cervical spinal cordUBERON:000646998.63gold quality
lower esophagus mucosaUBERON:003583498.62gold quality
esophagogastric junction muscularis propriaUBERON:003584198.59gold quality
left lobe of thyroid glandUBERON:000112098.56gold quality
lower esophagusUBERON:001347398.53gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-8894yes1597.85
E-ANND-3yes13.17
E-MTAB-10042yes8.66

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

20 targeting TBCA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-569699.9872.364487
HSA-MIR-472999.6972.184233
HSA-MIR-379-3P99.6969.601524
HSA-MIR-411-3P99.6969.631524
HSA-MIR-451999.4866.10859
HSA-MIR-6507-3P99.3567.321059
HSA-MIR-488-5P99.2868.12821
HSA-MIR-580-5P99.2870.941776
HSA-MIR-470599.1069.101091
HSA-MIR-548L99.0670.902560
HSA-MIR-1213598.9970.261814
HSA-MIR-508-3P98.6669.62887
HSA-MIR-203B-5P97.2468.54543
HSA-MIR-6718-5P97.2468.15553
HSA-MIR-71196.6065.75528
HSA-MIR-514A-3P96.4367.771048
HSA-MIR-514B-3P96.4367.771048

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 92.5% of screened cell lines, common-essential.

Literature-anchored findings (GeneRIF, showing 2)

  • TBCA is essential for cell viability and its knockdown produces a decrease in the amount of soluble tubulin, modifications in microtubules and G1 cell cycle arrest. (PMID:15963512)
  • overexpression of TBCA did not induce biocharacteristics that directly contrasted to those of TBCA knockdown (PMID:23740643)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriotbcaENSDARG00000016754
mus_musculusTbcaENSMUSG00000042043
rattus_norvegicusTbcaENSRNOG00000048342
drosophila_melanogasterTbcaFBGN0039869
caenorhabditis_eleganstbca-1WBGENE00021475

Protein

Protein identifiers

Tubulin-specific chaperone AO75347 (reviewed: O75347)

Alternative names: TCP1-chaperonin cofactor A, Tubulin-folding cofactor A

All UniProt accessions (8): O75347, A0A494C144, E5RHG6, E5RIW3, E5RIX8, E5RJD8, E5RJM1, Q6FGD7

UniProt curated annotations — full annotation on UniProt →

Function. Tubulin-folding protein; involved in the early step of the tubulin folding pathway.

Subunit / interactions. Supercomplex made of cofactors A to E. Cofactors A and D function by capturing and stabilizing tubulin in a quasi-native conformation. Cofactor E binds to the cofactor D-tubulin complex; interaction with cofactor C then causes the release of tubulin polypeptides that are committed to the native state.

Subcellular location. Cytoplasm. Cytoskeleton.

Similarity. Belongs to the TBCA family.

Isoforms (2)

UniProt IDNamesCanonical?
O75347-11yes
O75347-22

RefSeq proteins (3): NP_001284667, NP_001284669, NP_004598* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR004226TBCAFamily
IPR036126TBCA_sfHomologous_superfamily

Pfam: PF02970

UniProt features (9 total): helix 5, initiator methionine 1, chain 1, modified residue 1, splice variant 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
1H7CX-RAY DIFFRACTION1.8

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75347-F194.290.94

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 2

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-389977Post-chaperonin tubulin folding pathway
R-HSA-391251Protein folding
R-HSA-392499Metabolism of proteins

MSigDB gene sets: 187 (showing top): MORF_MBD4, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, MORF_RAD21, KYNG_DNA_DAMAGE_DN, PUJANA_CHEK2_PCC_NETWORK, MORF_SKP1A, GOBP_PROTEIN_MATURATION, KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS, MORF_ATOX1, MORF_PPP6C, MORF_PPP2R4, GOBP_PROTEIN_FOLDING, SCHLOSSER_SERUM_RESPONSE_DN, KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP

GO Biological Process (3): protein folding (GO:0006457), tubulin complex assembly (GO:0007021), post-chaperonin tubulin folding pathway (GO:0007023)

GO Molecular Function (5): RNA binding (GO:0003723), tubulin binding (GO:0015631), beta-tubulin binding (GO:0048487), protein-folding chaperone binding (GO:0051087), protein binding (GO:0005515)

GO Cellular Component (5): nucleolus (GO:0005730), cytoplasm (GO:0005737), microtubule (GO:0005874), microtubule cytoskeleton (GO:0015630), cytoskeleton (GO:0005856)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Protein folding1
Metabolism of proteins1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membraneless organelle2
cellular process1
protein maturation1
protein-containing complex assembly1
tubulin complex assembly1
nucleic acid binding1
cytoskeletal protein binding1
tubulin binding1
protein binding1
binding1
nuclear lumen1
intracellular anatomical structure1
cellular anatomical structure1
microtubule cytoskeleton1
polymeric cytoskeletal fiber1
cytoskeleton1

Protein interactions and networks

STRING

1672 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TBCATBCCQ15814690
TBCATUBA4AP05215676
TBCATBCBQ99426667
TBCATUBB2AQ13885617
TBCATBCDQ9BTW9603
TBCATUBBP05218562
TBCAA0A2R8Y809A0A2R8Y809536
TBCATBCEQ15813536
TBCAPFDN1O60925517
TBCATBCELQ5QJ74512
TBCATBC1D8BQ0IIM8440
TBCAARL2P36404436
TBCAPFDN2Q9UHV9420
TBCAHTTP42858368
TBCANARS2Q96I59364

IntAct

42 interactions, top by confidence:

ABTypeScore
TBCApsi-mi:“MI:0915”(physical association)0.590
TBCApsi-mi:“MI:0915”(physical association)0.590
TERF2IPTBCApsi-mi:“MI:0915”(physical association)0.510
ERBB3TBCApsi-mi:“MI:0915”(physical association)0.370
OTUB1EPM2Apsi-mi:“MI:0914”(association)0.350
BCAR1PSMD11psi-mi:“MI:0914”(association)0.350
BCAR1MYO1Cpsi-mi:“MI:0914”(association)0.350
STAT1KPNA6psi-mi:“MI:0914”(association)0.350
SOD1NPEPPSL1psi-mi:“MI:0914”(association)0.350
PRNPCARNS1psi-mi:“MI:0914”(association)0.350
PRNPWDR91psi-mi:“MI:0914”(association)0.350
CAV1ACOT7psi-mi:“MI:0914”(association)0.350
TRIM24DDTLpsi-mi:“MI:0914”(association)0.350
RIPK4TBCApsi-mi:“MI:0914”(association)0.350
TEKLANCL1psi-mi:“MI:0914”(association)0.350
MAPTSHTN1psi-mi:“MI:0914”(association)0.350
TUBB4BTUBA1Bpsi-mi:“MI:0914”(association)0.350
TBCAPLS1psi-mi:“MI:0914”(association)0.350
VCPSHTN1psi-mi:“MI:0914”(association)0.350
VCPFAM171A2psi-mi:“MI:0914”(association)0.350
CASP3NACApsi-mi:“MI:0914”(association)0.350
GATA2EFCAB5psi-mi:“MI:0914”(association)0.350
SMARCB1KIF2Apsi-mi:“MI:2364”(proximity)0.270
SMARCB1FAM186Apsi-mi:“MI:2364”(proximity)0.270
EPHA6ARHGAP32psi-mi:“MI:2364”(proximity)0.270
CFTRUBA6psi-mi:“MI:2364”(proximity)0.270

BioGRID (138): GDPGP1 (Co-fractionation), SEC31A (Co-fractionation), TBCA (Co-fractionation), TBCA (Co-fractionation), TBCA (Co-fractionation), TBCA (Co-fractionation), TBCA (Affinity Capture-MS), TBCA (Affinity Capture-MS), TBCA (Affinity Capture-RNA), TBCA (Affinity Capture-MS), FXN (Co-fractionation), LAP3 (Co-fractionation), LACTB2 (Co-fractionation), PMPCA (Co-fractionation), COA7 (Co-fractionation)

ESM2 similar proteins: A1A4P5, A1DGS2, A2R7Z2, B0BN18, O04350, O35685, O70591, O75347, O76031, P48427, P48428, P50502, P50503, P80584, Q07866, Q08851, Q08DB5, Q0VCY1, Q13190, Q15691, Q17QG2, Q3ZBD9, Q4SPU8, Q5D016, Q5R581, Q5R601, Q5R7N3, Q5R7Z5, Q5RF31, Q5U2U0, Q5ZLC7, Q5ZLF0, Q61166, Q63525, Q66HR2, Q66T82, Q68FJ8, Q6P848, Q6V291, Q8K1E0

Diamond homologs: O04350, O75347, P48427, P48428, P48606, P80584, P80585, Q6PEC1, Q75JC8, Q9Y703

SIGNOR signaling

1 interactions.

AEffectBMechanism
TBCA“up-regulates quantity by stabilization”Tubulinbinding

Disease & clinical

Clinical variants and AI predictions

ClinVar

14 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance11
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1405 predictions. Top by Δscore:

VariantEffectΔscore
5:77691494:TTTTC:Tacceptor_gain1.0000
5:77691495:TTTC:Tacceptor_gain1.0000
5:77691496:TTC:Tacceptor_gain1.0000
5:77691497:TC:Tacceptor_gain1.0000
5:77691498:CC:Cacceptor_gain1.0000
5:77691498:CCTAA:Cacceptor_loss1.0000
5:77691499:C:Aacceptor_loss1.0000
5:77691499:C:CCacceptor_gain1.0000
5:77691500:T:Aacceptor_loss1.0000
5:77691504:A:ACacceptor_gain1.0000
5:77693260:GCTTA:Gdonor_loss1.0000
5:77693261:CTTA:Cdonor_loss1.0000
5:77693262:TTA:Tdonor_loss1.0000
5:77693263:TACTA:Tdonor_loss1.0000
5:77693264:A:ACdonor_gain1.0000
5:77693264:A:Tdonor_loss1.0000
5:77693265:C:CGdonor_gain1.0000
5:77693265:CT:Cdonor_gain1.0000
5:77693265:CTA:Cdonor_gain1.0000
5:77693265:CTAG:Cdonor_gain1.0000
5:77693265:CTAGT:Cdonor_gain1.0000
5:77708237:TTTAC:Tdonor_loss1.0000
5:77708238:TTA:Tdonor_loss1.0000
5:77708239:TACCT:Tdonor_loss1.0000
5:77708240:A:Tdonor_loss1.0000
5:77708241:CCTG:Cdonor_gain1.0000
5:77708244:G:Adonor_gain1.0000
5:77708343:CCAAC:Cacceptor_gain1.0000
5:77708344:CAAC:Cacceptor_gain1.0000
5:77708344:CAACC:Cacceptor_gain1.0000

AlphaMissense

713 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:77693334:A:GS60P0.995
5:77693279:A:GL78P0.994
5:77693302:C:AR70S0.994
5:77693302:C:GR70S0.994
5:77693324:A:GM63T0.994
5:77708313:C:GA30P0.994
5:77693303:C:GR70T0.993
5:77776205:C:GR18P0.993
5:77708337:C:TE22K0.992
5:77693303:C:AR70M0.991
5:77693324:A:TM63K0.991
5:77776226:A:CI11S0.991
5:77776226:A:GI11T0.991
5:77708336:T:AE22V0.990
5:77693292:C:GA74P0.989
5:77693342:A:GL57P0.989
5:77708325:A:GY26H0.989
5:77693311:G:CC67W0.988
5:77776237:T:AR7S0.987
5:77776237:T:GR7S0.987
5:77776211:A:TV16E0.986
5:77776226:A:TI11N0.986
5:77693324:A:CM63R0.983
5:77693337:C:TE59K0.983
5:77708336:T:GE22A0.983
5:77776238:C:GR7T0.981
5:77693313:A:GC67R0.980
5:77693312:C:TC67Y0.979
5:77708303:T:GQ33P0.979
5:77691455:G:TA97E0.978

dbSNP variants (sampled 300 via entrez): RS1000013429 (5:77754185 T>A,C), RS1000049539 (5:77705074 A>G), RS1000053839 (5:77725786 C>A), RS1000107723 (5:77738398 T>G), RS1000216783 (5:77777459 G>A), RS1000270452 (5:77733886 A>G), RS1000310659 (5:77698578 C>T), RS1000338434 (5:77702878 G>A,C,T), RS1000394883 (5:77691437 G>A), RS1000397896 (5:77696603 A>G), RS1000399349 (5:77777345 C>T), RS1000450998 (5:77735928 T>C), RS1000505439 (5:77731218 C>A,T), RS1000518055 (5:77758730 AG>A), RS1000537520 (5:77731511 A>T)

Disease associations

OMIM: gene MIM:610058 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST004599_31Mean platelet volume2.000000e-10
GCST010796_5447Electrocardiogram morphology (amplitude at temporal datapoints)3.000000e-08
GCST010796_5448Electrocardiogram morphology (amplitude at temporal datapoints)5.000000e-08
GCST010796_5449Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-08
GCST90000025_43Appendicular lean mass1.000000e-10
GCST90002395_452Mean platelet volume1.000000e-09
GCST90002395_453Mean platelet volume6.000000e-13
GCST90002401_164Platelet distribution width1.000000e-17
GCST90002401_165Platelet distribution width1.000000e-27
GCST90002402_774Platelet count1.000000e-13

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004327electrocardiography
EFO:0004980appendicular lean mass
EFO:0007984platelet component distribution width
EFO:0004309platelet count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6066315 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.04Kd9.129nMCHEMBL5653589
8.04ED509.129nMCHEMBL5653589

PubChem BioAssay actives

1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149552: Binding affinity to human TBCA incubated for 45 mins by Kinobead based pull down assaykd0.0091uM

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteaffects cotreatment, increases abundance, increases expression, decreases expression2
triphenyl phosphateaffects expression1
arseniteincreases reaction, affects binding1
cobaltous chlorideincreases expression1
manganese chlorideaffects cotreatment, increases abundance, increases expression1
3,4,3’,4’-tetrachlorobiphenylaffects expression1
microcystin RRdecreases expression1
chloropicrinaffects expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
bisphenol Sincreases expression1
LDN 193189decreases expression, affects cotreatment1
bisphenol AFincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicaffects cotreatment, increases abundance, increases expression1
Doxorubicindecreases expression1
Ivermectindecreases expression1
Manganeseincreases expression, affects cotreatment, increases abundance1
Phenobarbitalaffects expression1
Theophyllineincreases expression1
Thiramincreases expression1
Tobacco Smoke Pollutionaffects expression1
Tretinoindecreases expression1
Sodium Seleniteincreases expression1
Cadmium Chlorideincreases expression1
beta-Naphthoflavoneincreases expression1
Particulate Matterdecreases expression, increases abundance1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5652594BindingBinding affinity to human TBCA incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.